Company Overview
New Path Molecular Research Ltd is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Thursday 29 January 2015, so this is a well established company. New Path Molecular Research Ltd has been in business for 11 years and 2 months. The accounts status is micro entity and the accounts are next due on Saturday 28 February 2026.
Registered Address

Building 580 Babraham Research Campus, Cambridge, Cambridgeshire, CB22 3AT
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameNEW PATH MOLECULAR RESEARCH LTD
Company Number09412383
Registered Office AddressBuilding 580 Babraham Research Campus
 CB22 3AT
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date29/01/2015
Accounting Reference Date Day31
Accounting Reference Date Month5
Accounts Next Due Date28/02/2027
Accounts Last Made Up Date31/05/2025
Accounts Account CategoryMICRO ENTITY
Returns Next Due Date26/02/2017
Returns Last Made Up Date29/01/2016
Directors & Members
Show Resigned
Elizabeth Farrant - Director
(British, 56 years old, born June 1970)
Appointed 29 January 2015
 Active
Beatrice Leigh - Director
(British, 75 years old, born November 1951)
Appointed 15 May 2017
 Active
Andrew MacCormack - Director
(British, 62 years old, born November 1964)
Appointed 07 May 2015
 Active
Nikzad Nikbin-Roudsari - Director
(British, 55 years old, born January 1971)
Appointed 07 May 2015
 Active
Deepbridge Ned Limited - Director
Appointed 13 February 2024
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
Elizabeth Farrant
CYCLOFLUIDIC LIMITED
Beatrice Leigh
OPTIMION TOPCO LIMITED
Andrew MacCormack
BEES ABROAD
BYZAS CONSULTANCY LIMITED
CATER-LYNE LIMITED
CLARK&SONS MAINTENANCE SERVICES LTD
EARTHRHIZE LTD
INTERVATE LIMITED
INTERVATE RENEWABLE ENERGY LIMITED
INTERVATE WASTE MANAGEMENT LIMITED
INTERVATE WASTE WATER LIMITED
LAZULI PARTNERS LLP
MARR-MUNNING TRUST
THERMAL MACHINERY SPECIALISTS LTD
WORLD'S END RECORDS LIMITED
Nikzad Nikbin-Roudsari
NEWPATH MOLECULAR LTD
Deepbridge Ned Limited
ARBNCO LTD
ARTERIUS LIMITED
CAROCELL BIO LIMITED
CHECKBOARD LIMITED
CIRCADA LIMITED
FEN EP LIMITED
FILISIA INTERFACES LTD
FLUORETIQ LIMITED
GREYLIST TRACE LIMITED
HURRICANE MODULAR COMMERCE LIMITED
IBISVISION LIMITED
INAVYA VENTURES LTD
L3M TECHNOLOGIES LIMITED
LCC THERAPEUTICS LTD.
MOLMART LTD.
PLASMA FRESH LIMITED
SCHOOL WELLBEING ACCELERATOR LTD
SMALLSPARK SPACE SYSTEMS LIMITED
TRIGENEX LTD
VIDEREGEN LIMITED
VOXSMART LIMITED
Balance Sheet Unlock full report
Accounts Date 31-May-2025 31-May-2022 31-May-2021
Balance Sheet
Fixed Assets 3,947 3,947 11,585
Current Assets 319,568 319,568 428,266
Creditors Due Within One Year 7,927 7,927 5,597
Working Cap 311,641 311,641 422,669
Total Assets Less Current Liabilities 315,588 315,588 434,254
Long-term Liabilities 39,838 39,838 44,982
Net Assets 275,750 275,750 389,272
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds 275,750 275,750 389,272
Common Size Financial Analysis Unlock full report
Accounts Date 31-May-2025 31-May-2022 31-May-2021
Tangible Fixed Assets - - -
Fixed Assets 1.2% 1.2% 2.6%
Stocks Inventory - - -
Debtors - - -
Cash Bank In Hand - - -
Current Assets 98.8% 98.8% 97.4%
Creditors Due Within One Year 2.5% 2.5% 1.3%
Net Current Assets Liabilities 96.3% 96.3% 96.1%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds 85.2% 85.2% 88.5%
Capital Employed - - -
Total Assets Less Current Liabilities 97.5% 97.5% 98.7%
Financial Ratio Analysis Unlock full report
Accounts Date 31-May-2025 31-May-2022 31-May-2021
Liquidity Ratio 40.3 40.3 76.5
Solvency Ratio 6.8 6.8 8.7
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-May-2025 31-May-2022 31-May-2021
Assets 323,515 323,515 439,851
Debt 47,765 47,765 50,579
Net Assets/Debt 275,750 275,750 389,272

The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.

The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

Unlock full report  The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.   The following is based on the accounts data presented in this report sourced from Companies House, however the company has filed later accounts. Our analysis of the latest account can be viewed by unlocking our full report.The company balance sheet displays a comfortable surplus of working capital. We would normally view this positively. Total reserves including retained profitability and movement in reserves has some deficiency. For the size of the company inferred by the balance sheet the level of net assets suggests a comfortable level of cover for total debts and obligations.

This review of public record balance sheet and company status information is presented under the terms of Open Government Licence and is for informational purposes only, is general in nature, and is not intended as an opinion or advice for any specific circumstances. The commentary and the colour band score is not a credit rating or credit risk assessment.

This review does not constitute a full credit rating or credit risk assessment based on the full analysis and credit score algorithms used in our credit reports. A full credit report may also provide information relating to trade payment history and county court or court judgments if any.

Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around CB22 3AT
WARWICK EFFECT POLYMERS LIMITED
Babraham Research Campus, Babraham, Cambridge, CB22 3AT
ARTIOS PHARMA LIMITED
BABRAHAM HALL, BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT
DENCEPTOR THERAPEUTICS LIMITED
Babraham Research Campus, Babraham, Cambridge, CB22 3AT
PIXL BIO LTD
MONETA BUILDING BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3AT
BABRAHAM INSTITUTE ENTERPRISE LIMITED
BABRAHAM HALL, BABRAHAM, CAMBRIDGE, CAMBRIDGESHIRE, CB22 3AT
ABZENA (CAMBRIDGE) LIMITED
BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3AT
IMMUNOBIOLOGY LIMITED
BABRAHAM RESEARCH CAMPUS, BABRAHAM, CAMBRIDGE, CB22 3AT
CAMBRIDGE BIOTECHNOLOGY LIMITED
C/O Bdo Llp, 5 Temple Square, Temple Street, Liverpool, CB22 3AT
CELL GUIDANCE SYSTEMS LIMITED
MAIA BUILDING,, BABRAHAM RESEARCH CAMPUS, CAMBRIDGE, CB22 3AT
ABZENA HOLDINGS LIMITED
Babraham Research Campus, Babraham, Cambridge, CB22 3AT
Document Filings
Confirmation statement made on 29 January 2026 with updates
Statement of capital following an allotment of shares on 21 January 2026
Statement of capital following an allotment of shares on 3 August 2025
Statement of capital following an allotment of shares on 30 May 2025
Statement of capital following an allotment of shares on 3 April 2025
Confirmation statement made on 29 January 2025 with updates
Statement of capital following an allotment of shares on 24 July 2024
Statement of capital following an allotment of shares on 8 April 2024
Statement of capital following an allotment of shares on 4 April 2024
Second filing of a statement of capital following an allotment of shares on 5 March 2024
Statement of capital following an allotment of shares on 5 March 2024
Appointment of Deepbridge Ned Limited as a director on 13 February 2024
Statement of capital following an allotment of shares on 23 January 2024
Termination of appointment of Paul Hedgeland as a director on 13 February 2024
Confirmation statement made on 29 January 2024 with updates
Confirmation statement made on 29 January 2023 with no updates
Confirmation statement made on 29 January 2022 with updates
Confirmation statement made on 29 January 2021 with no updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free